.

ALKERMES reported -34457000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Acorda Therapeutics ACOR:US $ -13.92M 2.79M
Amgen AMGN:US $ 2176M 324M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Bristol Myers Squibb BMY:US $ 2590M 37M
Coherus Biosciences CHRS:US $ -44.01M 43.13M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Gilead Sciences GILD:US $ 2029M 1832M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Horizon Pharma HZNP:US $ 88.56M 105.76M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
JAZZ PHA JAZZ:US $ 85.55M 2M
Johnson & Johnson JNJ:US $ 5840M 22M
Marinus Pharmaceuticals MRNS:US $ -36.77M 20.06M
Merk MRK:US $ 4927M 642M
Minerva Neurosciences NERV:US $ -6.96M 1.02M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Otsuka Holdings 4578:JP Y 46397M 25648M
Pfizer PFE:US $ 12102M 2229M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M